Better Choice Co. Files 8-K for Disclosure
Ticker: SRXH · Form: 8-K · Filed: Oct 18, 2024 · CIK: 1471727
Sentiment: neutral
Topics: disclosure, filing
TL;DR
Better Choice Co. filed a standard 8-K, no major news.
AI Summary
Better Choice Company, Inc. filed an 8-K on October 18, 2024, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting requirements.
Why It Matters
This filing indicates that Better Choice Company, Inc. is adhering to its reporting obligations with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for disclosure and does not appear to contain any new material information that would significantly impact the company's risk profile.
Key Players & Entities
- Better Choice Company, Inc. (company) — Registrant
- October 18, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- Tampa, Florida (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is Better Choice Company, Inc.
In which state is Better Choice Company, Inc. incorporated?
Better Choice Company, Inc. is incorporated in Delaware.
What is the address of the principal executive offices?
The address of the principal executive offices is 12400 Race Track Road, Tampa, Florida 33626.
What is the registrant's telephone number?
The registrant's telephone number is (212) 896-1254.
Filing Stats: 1,274 words · 5 min read · ~4 pages · Grade level 15.1 · Accepted 2024-10-18 07:24:07
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value share BTTR NYSE American
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex99-1.htm (EX-99.1) — 30KB
- ex99-1_001.jpg (GRAPHIC) — 48KB
- 0001493152-24-041494.txt ( ) — 323KB
- bttr-20241018.xsd (EX-101.SCH) — 3KB
- bttr-20241018_lab.xml (EX-101.LAB) — 33KB
- bttr-20241018_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 18, 2024 Better Choice Company, Inc. (Exact name of Registrant as Specified in its Charter) Delaware 001-40477 83-4284557 (State or other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 12400 Race Track Road Tampa , Florida 33626 (Address of Principal Executive Offices) (Zip Code) (Registrant's Telephone Number, Including Area Code): ( 212 ) 896-1254 N/A (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.001 par value share BTTR NYSE American Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 7.01. Regulation FD Disclosure On October 18, 2024, the Company issued a press release updating its stockholders regarding the progress on its previously announced acquisition of SRx Health Solutions Inc. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference. The information in Item 7.01 of this Current Report shall not be deemed to be "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. Forward-Looking This current report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the "safe harbor" created by those sections. All statements in this current report that are not based on historical fact are "forward looking statements." These statements may be identified by words such as "estimates," "anticipates," "projects," "plans," "strategy," "goal," or "planned," "seeks," "may," "might", "will," "expects," "intends," "believes," "should," and similar expressions, or the negative versions thereof, and which also may be identified by their context. All statements that address operating performance or events or developments the Company expects or anticipates will occur in the future, such as stated objectives or goals, refinement of strategy, attempts to secure additional financing, exploring possible business alternatives, or that are not otherwise historical facts, are forward-looking information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements as a result of various factors, including risks associated with the Company's ability to obtain additional capital in the future, the proposed transaction with SRx, general economic factors, competition in the industry and other factors that could cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Additional risks and uncertainties are described in or implied by the Risk Factors and Management's Discussion and Analysis of Financial Condition and Results of Operations sections of the Company's 2023 Annual Report on Form 10-K, filed on April 12, 2024 and other reports filed from time to time with the Securities and Exchange Commission ("SEC"). The Company urges you to consider those risks and uncertainties in evaluating its forward-looking statements. Readers are cautioned t